J.ophthalmol.(Ukraine).2019;1:61-64.

http://doi.org/10.31288/oftalmolzh201916164

Received: 24 December  2018; Published: 28 February 2018 

Combined Treatment for Recurrent Herpetic Stromal Keratitis with Ulceration: a Case Report

L.F. Troychenko, Cand. Med. Sc; T.B. Gaydamaka, Dr. Med. Sc.; G.I. Drozhzhyna, Dr. Med. Sc., Prof. 

Filatov Institute of Eye Diseases and Tissue Therapy, NAMS of Ukraine; 

Odessa (Ukraine) 

E-mail: tlf2008@ukr.net

Herpes simplex keratitis (HSK) is a severe ophthalmic pathology which comprises 20-50% of inflammatory diseases in the cornea. Since keratitis is characterized by a long-term duration, severity, and a tendency to recurrence, studies on ophthalmic herpes and searches for new treatments are of great relevance. 

Our clinical case demonstrated successful combined treatment of a recurrent stromal herpetic corneal lesion with ulceration. Both treatments, conservative (complex etiotropic, anti-viral, anti-inflammatory, and nutrition-improving) and surgical (an onlay technique), were successful. At 12 months after surgery, the patients had no pain syndrome; the corneal surface was epithelialized. No recurrence of herpetic keratitis was observed. 

Thus, a combination of etiotropic pathogenic treatment and AM transplantation appears to be effective for severe long-lasting recurrent herpetic keratitis with the presence of defects on the corneal surface.

Keywords: herpetic keratitis, treatment

References

  1. Anina EI, Martoplyas KV. [Corneal Pathology among adult population in Ukraine]. [Proceedings of XII Ukrainian Congress of Ophthalmologists, 26-28 May 2010]. Odessa; 2010:5. Russian.
  2. Kasparov AA. [Treatment of Herpes virus keratitis: 35 year experience]. [New technologies in treatment of corneal diseases: All-Russian Scientific Practical Conference with international participations, Fedorov Memorial Lectures, 25-26 June 2004: collection of papers]. M.;2004: 574-80. Russian. 
  3. Dembskii LK, Shirshova ON, Mironiuk OV. [Some aspects of organization of virus keratitis treatment]. [Surgical treatment and rehabilitation of patients with ophthalmic pathology: scientific and practical conference with international participation, 2004: proceedings]. K.; 2004: 99-100.  Russian. 
  4. Kasparov AA. [Treatment of herpes virus keratitis. In: Current issues of herpes virus infections]. M.; 2004: 31-7. Russian. 
  5. Kasparov AA. [Modern methods for herpes virus keratitis]. [Scientific and Practical conference “Modern methods of diagnostics and treatment for cornea and sclera diseases”]. M.;2007:273-6. Russian. Современные методы лечения герпесвирусного кератита // Научно-практич. 
  6. Kaye S, Choudhary A. Herpes simplex keratitis. Progress in retinal and eye research. 2006;25(4):355 – 380. 
  7. Kovalchuk LV, Gankovskaya LV, Martirosova NI, Vasilenkova LV, Sokolova EV, Levchenko VA. [The approaches to immunocorrecting therapy in ophthalmology on position of new presentation about inherent immunity] Refraktsionnaia khirurgiia I oftalmologiia. 2008;1:44-8. Russian.  
  8. Pozdnyakov VI, Maichuk YuF, Pozdnyakova VV. [Algorithm of a therapy for severe ophthalmic herpes]. [Current issues of inflammatory eye diseases: scientific and practical conference, 20-21 November, 2001: proceedings]. M.;2001:151-3. Russian.  
  9. Kasparov AA. [Modern methods of treatment for severe infectious diseases of the cornea]. [IX Congress of Ophthalmologists of Russia, 16-18 June 2010: proceedings]. M.; 2010:296-8. Russian.
  10. Gaydamaka TB. [Antirelapse treatment of the patients with herpetic keratites]. Oftalmol Zh. 2009;5:6-9. Russian. 
  11. Sereda EV, Drozhzhina GI, Gaidamaka TB, Ivanovskaia EV, Ostashevskii VL, Ivanova ON, Kogan BM. [Efficacy of different amniotic membrane transplantation techniques in patients with inflammatory and degenerative pathology of the cornea]. Oftalmol Zh. 2016;4:3-10. Russian.  
  12. Kim JC, Tseng SC. Transplantation of preserved human amniotic membrane for surface reconstruction in severely damaged rabbit corneas. Cornea. 1995;14:473–84.
  13. Trufanov SV. [The use of preserved human amniotic membrane in reconstructive surgery of the eye]. Author’s thesis for Cand. Med. Sc. M.:2004. 24p. Russian.  
  14. Fedorova EA. [The use of lyophilized amniotic membrane in treatment of inflammatory corneal diseases]. Author’s thesis for Cand. Med. Sc. M.:2004. 24p. Russian.  
  15. Seitz B. Amniotic membrane transplantation. An indispensable therapy option for persistent corneal epithelial defects. Ophthalmologe. 2007;104:1075–9.
  16. Shortt AJ, Secker GA, Notara MD et al. Transplantation of ex vivo cultured limbal epithelial stem cells: a review of techniques and clinical results. Surv Ophthalmol. 2007;52:483–502.
  17. Koizumi NJ, Inatomi TJ, Sotozono CJ, Fullwood NJ, Quantock AJ, Kinoshita S.  Growth factor mRNA and protein in preserved human amniotic membrane. Curr Eye Res. 2000;20:173–7.
  18. Tseng SC, Espana EM, Kawakita T et al. How does amniotic membrane work? Ocul Surf. 2004;2:177–87.
  19. Sippel KC, Ma JJ, Foster CS. Amniotic membrane surgery. Curr Opin Ophthalmol. 2001;12:269–81.
  20. Ueta M, Kweon MN, Sano Y et al. Immunosuppressive properties of human amniotic membrane for mixed lymphocyte reaction. Clinical and Experimental Immunology. 2002;129:464–70.
  21. Kheirkhah A, Johnson DA, Paranjpe DR, Raju VK, Casas V, Tseng SC. Temporary sutureless amniotic membrane patch for acute alkaline burns. Arch Ophthalmol. 2008;126:1059–66.
  22. Thomasen H, Pauklin M, Steuhl KP, Meller D. Comparison of cryopreserved and air-dried human amniotic membrane for ophthalmologic applications. Graefes Arch Clin Exp Ophthalmol. 2009;247:1691–700.